시장보고서
상품코드
1087863

NGS 자동화 시장 : 제품, 시퀀싱 타입, 용도, 최종사용자별 - 예측(-2029년)

NGS Automation Market By Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Global Forecast to 2029

발행일: | 리서치사: Meticulous Market Research Pvt. Ltd. | 페이지 정보: 영문 172 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 NGS 자동화 시장 규모는 2029년까지 13억 3,000만 달러에 이르고, 2022-2029년에 연평균 복합 성장률(CAGR)로 13.4%의 성장이 예측됩니다. 생명과학 산업에서의 연구개발 활동 증가, 연구소에서의 NGS 자동화 수요 증가, 암 등의 만성질환 유병률 증가 등의 요인이 시장 성장에 박차를 가하고 있습니다.

세계의 NGS 자동화(NGS Automation) 시장에 대해 조사분석했으며, 시장 인사이트, 부문 분석, 지역 분석, 경쟁 구도 등의 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 인사이트

  • 시장 개요
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
  • 과제
  • COVID-19가 세계 NGS 자동화 시장에 미치는 영향
  • 가격 분석

제5장 세계의 NGS 자동화 시장 : 제품별

  • 서론
  • 워크스테이션/로봇 플랫폼
  • 시약 및 소모품

제6장 세계의 NGS 자동화 시장 : 시퀀싱 타입별

  • 서론
  • 전체 게놈 시퀀싱
  • 전체 엑솜 시퀀싱
  • 타겟 게놈 시퀀싱
  • 기타 시퀀싱 타입

제7장 세계의 NGS 자동화 시장 : 용도별

  • 서론
  • Drug Discovery
  • 임상 진단
    • 생식건강 진단
    • 종양 진단
    • 감염증 진단
    • 기타 임상 진단
  • 기타 용도

제8장 세계의 NGS 자동화 시장 : 최종사용자별

  • 서론
  • 제약 기업 및 바이오테크놀러지 기업
  • 병원 및 진단실험실
  • 학술기관 및 연구기관
  • 기타 최종사용자

제9장 NGS 자동화 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 기타 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 구도

  • 서론
  • 주요 성장 전략
  • 경쟁 벤치마킹
  • 시장 점유율 분석(2021년)
    • Danaher Corporation(미국)
    • Tecan Group Ltd.(스위스)
    • PerkinElmer, Inc.(미국)
    • Agilent Technologies, Inc.(미국)
    • Thermo Fisher Scientific, Inc.(미국)

제11장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 개발)

  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • Hamilton Company
  • PerkinElmer, Inc.
  • Tecan Group Ltd.
  • PRIMADAG SAS
  • BRAND GMBH + CO KG
  • Hudson Robotics
  • SPT Labtech
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.

제12장 부록

LSH 22.06.22

NGS Automation Market by Product (Platform, Consumables), Application (Drug Discovery, Diagnostics), Sequencing Type (Whole Genome, WES, TGS), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic Research)-Global Forecast to 2029

The NGS Automation Market is expected to grow at a CAGR of 13.4% from 2022-2029 to reach $1.33 billion by 2029.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities in the NGS automation market. The growth of this market is driven by factors such as the increasing R&D activities in the life sciences industry, the growing demand for NGS automation in laboratories, and the increasing prevalence of chronic diseases such as cancer.

In addition, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for this market. However, the high cost of automation workstations is expected to hamper the adoption of NGS automation solutions and restrain the growth of this market. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the requirement of high-skilled personnel for operating automation software are the major challenges to the growth of this market.

Based on product, in 2022, the workstation/robotic platform segment is estimated to account for the largest share of the NGS automation market. The large share of this segment is attributed to factors such as the increasing demand for NGS automation solutions in laboratories and the benefits of NGS automation during library preparation compared to manual processes.

Based on application, the clinical diagnostic segment is slated to register the highest growth rate during the forecast period. The high growth of this segment is attributed to the increasing adoption of NGS by diagnostic laboratories to improve their capabilities in diagnosing rare genetic abnormalities, performing genetic profiling for precision oncology, and detecting pathogens in infectious diseases.

Based on sequencing type, in 2022, the whole genome sequencing segment is expected to account for the largest share of this market. The large market share of this segment is attributed to the high demand for NGS automation solutions for WGS to reduce per sample costs.

Based on end user, in 2022, the pharmaceutical & biotechnology companies segment is poised to command the largest share of this market. The large share of this segment is attributed to the increasing R&D expenditure by pharmaceutical and biotechnology companies and the rising demand for new drug development and discovery. Additionally, the financial capability of pharmaceutical & biotechnology companies to acquire highly sophisticated NGS automation workstations boosts the growth of this segment.

An in-depth analysis of the geographical scenario of the NGS automation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2022, North America is poised to command the largest share of the NGS automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the NGS automation market are Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PRIMADAG SAS (France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland).

Scope of the Report:

NGS Automation Market, by Product

  • Workstation/Robotic Platform
  • Reagents & Consumables

NGS Automation Market, by Application

  • Drug Discovery
  • Clinical Diagnostics
    • Oncology
    • Infectious Diseases
    • Reproductive Health
    • Other Clinical Diagnostics
  • Other Applications

NGS Automation Market, by Sequencing Type

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Genome Sequencing
  • Others

NGS Automation Market, by End User

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Others End Users

NGS Automation Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Growing Demand for Optimized & Streamlined NGS Workflows
    • 4.2.2. Rising Prevalence of Cancer
    • 4.2.3. Increasing Pharmaceutical R&D Investments and Healthcare Expenditures
  • 4.3. Restraints
    • 4.3.1. High Costs of Automation Workstations
  • 4.4. Opportunities
    • 4.4.1. Increasing Applications of Next-Generation Sequencing Technology
    • 4.4.2. Collaborations Between Vendors to Develop Library Preparation Protocols
  • 4.5. Challenges
    • 4.5.1. Regulatory & Standardization Concerns Related to Diagnostic Testing
    • 4.5.2. Need to Train Personnel on the Use of NGS Automation Software
  • 4.6. The Impact of COVID-19 on the Global NGS Automation Market
  • 4.7. Pricing Analysis
    • 4.7.1. NGS Automation Workstations: Pricing Details
    • 4.7.2. Factors Impacting Purchase Decisions

5. Global NGS Automation Market, by Product

  • 5.1. Introduction
  • 5.2. Workstations/Robotic Platforms
  • 5.3. Reagents & Consumables

6. Global NGS Automation Market, by Sequencing Type

  • 6.1. Introduction
  • 6.2. Whole Genome Sequencing
  • 6.3. Whole Exome Sequencing
  • 6.4. Targeted Genome Sequencing
  • 6.5. Other Sequencing Types

7. Global NGS Automation Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Clinical Diagnostics
    • 7.3.1. Reproductive Health Diagnostics
    • 7.3.2. Oncology Diagnostics
    • 7.3.3. Infectious Disease Diagnostics
    • 7.3.4. Other Clinical Diagnostics
  • 7.4. Other Applications

8. Global NGS Automation Market, by End User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Hospitals & Diagnostic Laboratories
  • 8.4. Academics & Research Institutes
  • 8.5. Other End Users

9. NGS Automation Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis (2021)
    • 10.4.1. Danaher Corporation (U.S.)
    • 10.4.2. Tecan Group Ltd. (Switzerland)
    • 10.4.3. PerkinElmer, Inc. (U.S.)
    • 10.4.4. Agilent Technologies, Inc. (U.S.)
    • 10.4.5. Thermo Fisher Scientific, Inc. (U.S.)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Agilent Technologies, Inc.
  • 11.2. Danaher Corporation
  • 11.3. Eppendorf AG
  • 11.4. Hamilton Company
  • 11.5. PerkinElmer, Inc.
  • 11.6. Tecan Group Ltd.
  • 11.7. PRIMADAG SAS
  • 11.8. BRAND GMBH + CO KG
  • 11.9. Hudson Robotics
  • 11.10. SPT Labtech
  • 11.11. Thermo Fisher Scientific, Inc.
  • 11.12. F. Hoffmann-La Roche Ltd

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제